Hiroji Shinkawa

2.0k total citations
107 papers, 1.2k citations indexed

About

Hiroji Shinkawa is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Hiroji Shinkawa has authored 107 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Surgery, 56 papers in Hepatology and 43 papers in Oncology. Recurrent topics in Hiroji Shinkawa's work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers) and Liver Disease Diagnosis and Treatment (26 papers). Hiroji Shinkawa is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers) and Liver Disease Diagnosis and Treatment (26 papers). Hiroji Shinkawa collaborates with scholars based in Japan, India and United States. Hiroji Shinkawa's co-authors include Shigekazu Takemura, Shoji Kubo, Shogo Tanaka, Shintaro Kodai, Masahiko Kinoshita, Kenjiro Kimura, Takuma Tsukioka, Ryosuke Amano, Shigeru Okada and Kiyoshi Hasegawa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Hiroji Shinkawa

96 papers receiving 1.2k citations

Peers

Countries citing papers authored by Hiroji Shinkawa

Since Specialization

Citations

This map shows the geographic impact of Hiroji Shinkawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroji Shinkawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroji Shinkawa more than expected).

Fields of papers citing papers by Hiroji Shinkawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroji Shinkawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroji Shinkawa. The network helps show where Hiroji Shinkawa may publish in the future.

Co-authorship network of co-authors of Hiroji Shinkawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroji Shinkawa. A scholar is included among the top collaborators of Hiroji Shinkawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroji Shinkawa. Hiroji Shinkawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Taste receptor type 1 member 3 in osteoclasts regulates osteoclastogenesis via detection of glucose 2025 ·Journal of Biological Chemistry ·(unknown), Takuma Matsubara, (unknown), Yoshimitsu Kakuta, (unknown), Ryusuke Yoshida, Osamu Kaminuma, Shuhei Hosomi, Hiroji Shinkawa, Quan Yuan, T. Kawamoto, Shoichiro Kokabu	1
2	Consequences of reported β-lactam allergy on perioperative outcomes: a systematic review and meta-analysis of surgical site infection risk 2025 ·Infection Control and Hospital Epidemiology ·Yuki Hanai, Jun Hirai, Kazuhiro Matsuo, Keita Kouzu, Hiroji Shinkawa, Seiichi Shinji, (unknown), Yuko Kitagawa, Chizuru Yamashita, Yasuhiko Mohri, (unknown), Katsunori Suzuki, Junzo Shimizu, Motoi Uchino, Seiji Haji, Masahiro Yoshida, Toru Mizuguchi, Toshihiko Mayumi, Hiroki Ohge	0
3	Individualized Prognostication Based on Deep‐Learning Models Using Computed Tomography as an Imaging Biomarker After Hepatocellular Carcinoma Resection 2025 ·Hepatology Research ·Hiroji Shinkawa, Daiju Ueda, (unknown), Masaki Kaibori, Masaki Ueno, Satoshi Yasuda, Hisashi Ikoma, Tsukasa Aihara, Takuya Nakai, Masahiko Kinoshita, Hisashi Kosaka, Shinya Hayami, (unknown), (unknown), Takayoshi Nakajima, (unknown), Takeaki Ishizawa	0
4	Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40–CD40 Ligand Linkage 2024 ·American Journal Of Pathology ·(unknown), Lê Thị Thanh Thủy, (unknown), Hoang Hai, (unknown), Misako Sato, Sawako Uchida‐Kobayashi, Hayato Urushima, (unknown), Nguyễn Thị Thu Hà, Hiroji Shinkawa, Shoji Kubo, Naoko Ohtani, Masaru Enomoto, Akihiro Tamori, Norifumi Kawada	1
5	Subsequent development of cholangiocarcinoma caused by exposure to 1,2-dichloropropane and/or dichloromethane in the printing company in Osaka, Japan 2024 ·Industrial Health ·Shoji Kubo, Masahiko Kinoshita, Yasunori Sato, Hiroji Shinkawa, Shogo Tanaka, Takeaki Ishizawa, Sakae Maeda, Atsushi Miyamoto, Shinji Kumagai, Ginji Endo	1
6	Deep Learning Model Based on Contrast-Enhanced Computed Tomography Imaging to Predict Postoperative Early Recurrence after the Curative Resection of a Solitary Hepatocellular Carcinoma 2023 ·Cancers ·Masahiko Kinoshita, Daiju Ueda, Toshimasa Matsumoto, Hiroji Shinkawa, Akira Yamamoto, Masatsugu Shiba, (unknown), Naoki Tani, Shogo Tanaka, Kenjiro Kimura, Go Ohira, Kohei Nishio, (unknown), Shoji Kubo, Takeaki Ishizawa	17
7	Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach 2023 ·Surgical Endoscopy ·Hiroji Shinkawa, Masaki Kaibori, Daijiro Kabata, Takuya Nakai, Masaki Ueno, Daisuke Hokuto, Hisashi Ikoma, Hiroya Iida, Koji Komeda, Shogo Tanaka, Hisashi Kosaka, (unknown), Shinya Hayami, Satoshi Yasuda, Ryo Morimura, Haruki Mori, (unknown), Shoji Kubo, Takeaki Ishizawa	2
8	Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma 2023 ·SHILAP Revista de lepidopterología ·Yasuhito Mitsuyama, Ken Kageyama, Hiroji Shinkawa, Akira Yamamoto, (unknown), (unknown), Shogo Tanaka, Shigekazu Takemura, Shoji Kubo, Takeaki Ishizawa, Yukio Miki	4
9	Surgical Outcomes for Hepatocellular Carcinoma in Patients with Child–Pugh Class B: a Retrospective Multicenter Study 2022 ·Journal of Gastrointestinal Surgery ·Shogo Tanaka, Takehiro Noda, Koji Komeda, Hisashi Kosaka, Hiroya Iida, Masaki Ueno, Daisuke Hokuto, Hisashi Ikoma, Takuya Nakai, Daijiro Kabata, Hiroji Shinkawa, Shogo Kobayashi, Fumitoshi Hirokawa, Haruki Mori, Shinya Hayami, Ryo Morimura, Masataka Matsumoto, Takeaki Ishizawa, Shoji Kubo, Masaki Kaibori	5
10	Association between the confluent form of pancreatic and bile duct and histopathological findings in pancreaticobiliary maljunction: A case series study 2021 ·Annals of Medicine and Surgery ·(unknown), Yoshiki Morotomi, Shigekazu Takemura, Shogo Tanaka, Hiroji Shinkawa, Shigeo Hashimoto, Kenichi Wakasa, Shoji Kubo	1
11	Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy 2020 ·Journal of Hepato-Biliary-Pancreatic Sciences ·Yasunori Sato, Shogo Tanaka, Masahiko Kinoshita, Shigekazu Takemura, Hiroji Shinkawa, Takashi Kokudo, Kiyoshi Hasegawa, Hiromu Tanaka, (unknown), Akira Mori, (unknown), Motoko Sasaki, Kenichi Harada, Shoji Kubo	14
12	The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with OccupationalCholangiocarcinoma 2018 ·PubMed ·Masahiko Kinoshita, Shigekazu Takemura, Shogo Tanaka, Hiroji Shinkawa, Genya Hamano, (unknown), (unknown), (unknown), Yasuni Nakanuma, Yasunori Sato, Shoji Nakamori, Akira Arimoto, Takatsugu Yamamoto, Hideyoshi Toyokawa, Shoji Kubo	4
13	Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: an intent-to-treat analysis 2018 ·HPB ·Chétana Lim, Hiroji Shinkawa, Kiyoshi Hasegawa, Prashant Bhangui, Chady Salloum, Concepción Gómez‐Gavara, Yoshihiro Sakamoto, (unknown), Norihiro Kokudo, Daniel Azoulay	0
14	Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status 2018 ·Liver Cancer ·(unknown), Shogo Tanaka, Shigekazu Takemura, Hiroji Shinkawa, Masahiko Kinoshita, Genya Hamano, (unknown), Norifumi Kawada, Toshihiko Shibata, Shoji Kubo	19
15	Portal Vein Embolization: History and Current Indications 2017 ·Visceral Medicine ·Hiroji Shinkawa, Shigekazu Takemura, Shogo Tanaka, Shoji Kubo	10
16	Repeated bile duct recurrence of hepatocellular carcinoma treated by repeated hepatic resection and transcatheter arterial chemoembolization: a report of super elderly case 2014 ·Kanzo ·Osamu Yamazaki, Hiroko Oka, Hiroji Shinkawa, (unknown)	0
17	Laparoscopic Resection of the Urachus for Umbilical Urachal Sinus 2013 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Yushi Fujiwara, Satoshi Takatsuka, (unknown), Hiroji Shinkawa	0
18	Case Report of Successful Treatment of Locally Advanced Breast Cancer with Mohs Paste 2012 ·Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) ·Satoshi Takatsuka, Hiroji Shinkawa, (unknown), Yushi Fujiwara	4
19	Effect of interferon therapy on first and second recurrence after resection of hepatitis C virus‐related hepatocellular carcinoma 2012 ·Hepatology Research ·(unknown), Shoji Kubo, Shigekazu Takemura, Chikaharu Sakata, Takahiro Uenishi, Shintaro Kodai, Hiroji Shinkawa, Yorihisa Urata, (unknown), Kazuhisa Kaneda, Takayoshi Nishioka, Akinori Nozawa, Shigefumi Suehiro	21
20	Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus 2007 ·Hepatology Research ·Shoji Kubo, Hiromu Tanaka, Shigekazu Takemura, Satoshi Yamamoto, Seikan Hai, Tsuyoshi Ichikawa, Shintaro Kodai, Hiroji Shinkawa, Hiroki Sakaguchi, Akihiro Tamori, Daiki Habu, Shuhei Nishiguchi	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact